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DNA Sequence Analysis of Regions Surrounding blaCMY-2 from
Multiple Salmonella Plasmid Backbones
W. P. Giles,1 A. K. Benson,2 M. E. Olson,3 R. W. Hutkins,2 J. M. Whichard,4
P. L. Winokur,5 and P. D. Fey3,6*
Departments of Biology1 and Food Science,2 University of Nebraska—Lincoln, Lincoln, and Departments of Internal
Medicine3 and Pathology and Microbiology,6 University of Nebraska Medical Center, Omaha, Nebraska; Foodborne
and Diarrheal Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for
Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia4;
and Department of Internal Medicine, University of Iowa and Veterans
Affairs Medical Center, Iowa City, Iowa5

The emergence in the United States of resistance to expanded-spectrum cephalosporin (e.g., ceftriaxone)
within the salmonellae has been associated primarily with three large (>100-kb) plasmids (designated types
A, B, and C) and one 10.1-kb plasmid (type D) that carry the blaCMY-2 gene. In the present study, the distribution of these four known blaCMY-2-carrying plasmids among 35 ceftriaxone-resistant Salmonella isolates
obtained from 1998 to 2001 was examined. Twenty-three of these isolates were Salmonella enterica serotype
Newport, 10 were Salmonella enterica serotype Typhimurium, 1 was Salmonella enterica serotype Agona, and 1
was Salmonella enterica serotype Reading. All 23 serotype Newport isolates carried a type C plasmid, and 5, 4,
and 1 serovar Typhimurium isolate carried type B, A, and C plasmids, respectively. Both the serotype Agona
and serotype Reading isolates carried type A plasmids. None of the isolates carried a type D plasmid.
Hybridization data suggested that plasmid types A and C were highly related replicons. DNA sequencing
revealed that the region surrounding blaCMY-2 was highly conserved in all three plasmid types analyzed (types
B, C, and D) and was related to a region surrounding blaCMY-5 from the Klebsiella oxytoca plasmid pTKH11.
These findings are consistent with a model in which blaCMY-2 has been disseminated primarily through plasmid
transfer, and not by mobilization of the gene itself, to multiple Salmonella chromosomal backbones.
patients. Ceftriaxone is the expanded-spectrum cephalosporin
used most often for pediatric patients, because its long half-life
allows for a single daily administration, whereas other antibiotics require two to three daily doses. The fluoroquinolones
(e.g., ciprofloxacin) are often used for treatment of salmonellosis in adults but are not approved for use in pediatric patients.
Decreased susceptibility (MIC, 16 to 32 g/ml) or resistance
(MIC, ⱖ64 g/ml) to ceftriaxone within the salmonellae is a
growing public health concern. Since 1991, Salmonella serotypes resistant to expanded-spectrum cephalosporins have
been reported worldwide (1, 4, 9, 14, 35). From these isolates,
a wide variety of ␤-lactamases belonging to Bush groups 1 and
2be have been described (10). In the United States before
1996, all reported cases of infection with ceftriaxone-resistant
salmonellae were known or believed to be acquired abroad
(19). However, the prevalence of ceftriaxone resistance (or
decreased susceptibility) among Salmonella isolates from humans increased more than sevenfold from 1996 to 1998, from
1 of 1,272 (0.1%) isolates in 1996 to 5 of 2,205 (0.2%) isolates
in 1997 and 9 of 1,466 (0.6%) in 1998 (14). Year-2001 data
from the National Antimicrobial Resistance Monitoring System (NARMS) demonstrated that 3% of non-serotype Typhi
Salmonella isolates from humans exhibited decreased susceptibility to ceftriaxone while 2% were resistant to ceftriaxone
(12). A similar study performed in the state of Nebraska in
2000 demonstrated that decreased susceptibility to ceftriaxone
reached 6.5% within the salmonellae and 18% among all Salmonella enterica serotype Typhimurium isolates (P. D. Fey,

Salmonellae are a leading cause of food-borne illness
throughout the world. Although the worldwide incidence is not
known, in the United States alone there are an estimated 1.4
million cases of salmonellosis each year. Nearly all of these
cases (95%) are thought to be due to transmission of the
bacteria in contaminated foods such as eggs, dairy products,
produce, and meats (33). Typically, salmonellae cause a selflimiting gastroenteritis that does not require treatment with
antibiotics. Antimicrobial agents are usually not essential for
the treatment of patients with Salmonella infections; for such
patients, antimicrobial agents may not reduce the severity of
the gastrointestinal symptoms and may prolong the duration of
the carrier state (2). Antimicrobial agents may be life-saving,
however, for patients with severe invasive infection. Septicemia
occurs in approximately 6% of the 30,000 to 32,000 cultureconfirmed cases of salmonellosis in the United States annually
(19, 33; http://www.cdc.gov/foodnet; http://www.cdc.gov/ncidod
/dbmd/phlisdata/default.htm). Invasive infections commonly
occur in children, particularly in infants. In the United States,
10% of culture-confirmed infections in which salmonellae were
isolated from the blood or central nervous system occurred in
infants ⱕ1 year old (22, 32). Expanded-spectrum cephalosporins (e.g., ceftriaxone and cefotaxime) are the antimicrobial
agents of choice for invasive Salmonella infections of pediatric
* Corresponding author. Mailing address: University of Nebraska
Medical Center, 985400 Nebraska Medical Center, Omaha, NE 681985400. Phone: (402) 559-2122. Fax: (402) 559-5581. E-mail: pfey@unmc
.edu.
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TABLE 1. Ceftriaxone-resistant Salmonella strains used in the study
Antibiotic resistance
phenotypea

1041
5313
5501
5653
7073
7075
7079
7467
8611
8683
6163
7040
7041
5561
6100
712
2231
4962
5299
5924
6980
10091
2050
5436
5655
5678
5927
5965
6191
6516
1568
2000
2232
2042
2151

Newport (A)
Newport (A)
Newport (A)
Newport (A)
Newport (A)
Newport (A)
Newport (A)
Newport (A)
Newport (A)
Newport (A)
Newport (B)
Newport (B)
Newport (B)
Newport (C)
Newport (C)
Newport (D)
Newport (D)
Newport (E)
Newport (E)
Newport (F)
Newport (G)
Newport (H)
Newport (I)
Typhimurium
Typhimurium
Typhimurium
Typhimurium
Typhimurium
Typhimurium
Typhimurium
Typhimurium
Typhimurium
Typhimurium
Agona
Reading

ACSSuTCroFx
ACSSuTCroFx
ACSSuTCroFx
ACSSuTCroFx
ACSSuTCroFx
ACSSuTCroFx
ACSSuTCroFx
ACSSuTCroFx
ACSSuTCroFx
ACSSuTCroFx
ACSSuSxtTCroFx
ACSSuSxtTCroFx
ACSSuSxtTCroFx
ACSSuTCroFx
ACSSuTCroFx
ACSSuSxtTCroFx
ACSSuSxtTCroFx
ACSSuTCroFx
ACSSuTCroFx
ACSSuTKCroFx
ACSSuTCroFx
ACSSuTCroFx
ACSSuTCroFx
ACroFx
ACSSuTCroFx
ACSSuTCroFx
ACSSuTCroFx
ACroFx
ACroFx
ACroFx
ACSSuTCroFx
ACSSuTKCroFx
ACSSuTCroFx
ACSSuSxtTCroFx
ACSSuTKCroFx

E. coli
backgroundb

Antibiotic resistance
phenotype of E. colic

Plasmid
type

State of
origin

Yr of
isolation

D10

Same as wild type

DH

Same as wild type

D10

Same as wild type

D10
D10

Same as wild type
Same as wild type

D10

All except Sxt

C6

Same as wild type

D10
D10
D10

All except Sxt
Same as wild type
Same as wild type

D10
DH
D10
D10
D10B
D10
C6
C6
C6
C6
C6
D10
D10
D10
D10
D10

Same as wild type
Same as wild type
Same as wild type
Same as wild type
Same as wild type
Same as wild type
Same as wild type
All except SSuT
Same as wild type
Same as wild type
Same as wild type
Same as wild type
Same as wild type
Same as wild type
Same as wild type
All except K

C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
B
C
A
B
B
B
B
A
A
A
A
A

Nebr.
Minn.
N.J.
Fla.
Mass.
Mass.
Mass.
Oreg.
Tenn.
Wash.
Ga.
Mass.
Mass.
N.Y.
Calif.
Nebr.
Nebr.
Colo.
Colo.
Kans.
N.J.
Md.
Nebr.
Ga.
Fla.
Kans.
Kans.
Conn.
Ga.
N.J.
Nebr.
Nebr.
Nebr.
Nebr.
Nebr.

1999
1999
1999
1999
1999
1999
1999
1999
2000
2000
1999
1999
1999
1999
1999
1999
2000
1999
1999
1999
1999
2001
2000
1999
1999
1999
1999
1999
1999
1999
2000
2000
2000
2000
2000

a
Abbreviations: A, ampicillin; C, chloramphenicol; S, streptomycin; Su, sulfisoxazole; Sxt, trimethoprim-sulfamethoxazole; T, tetracycline; K, kanamycin; Cro,
ceftriaxone; Fx, cefoxitin.
b
Background to which plasmid was transferred via conjugation (C6), transformation (DH), or electroporation (D10).
c
“All except” indicates resistance to the same antimicrobial agents as the wild-type Salmonella strain, except for the particular antimicrobials noted. “Same as wild
type” indicates resistance to the same antimicrobial agents as the wild-type Salmonella strain.

S. L. Greenwood, A. R. Sambol, P. C. Iwen, M. E. Rupp, T. J.
Safranek, and S. H. Hinrichs, Abstr. 101st Gen. Meet. Am.
Soc. Microbiol., abstr. 203, 2001).
In the United States, decreased susceptibility to ceftriaxone
in domestically acquired Salmonella infections is almost exclusively mediated through the production of the Citrobacter
freundii-derived blaCMY-2 cephamycinase (14, 17, 29, 36). Previous restriction fragment length polymorphism (RFLP) and
Southern blot experiments have demonstrated that blaCMY-2 is
carried on at least three separate large (⬎100-kb) plasmid
replicons termed types A, B, and C as well as on a 10-kb
plasmid described by Winokur et al. (11, 38). From 1996 to
1999, these blaCMY-2-carrying plasmids were isolated most frequently from serotype Typhimurium (14). However, since
2000, blaCMY-2-carrying plasmids have been isolated at a substantial rate from isolates representing an apparently highly
related strain of Salmonella enterica serotype Newport (6, 17,
29). Decreased susceptibility to ceftriaxone was noted in 25%
of all serotype Newport isolates collected from humans in 2001
through the NARMS program (12).
The purpose of this study was to determine the extent to

which the four known blaCMY-2-carrying plasmid replicons
were found in 35 ceftriaxone-resistant Salmonella isolates obtained throughout the United States from 1999 to 2001. In
addition, the DNA sequence that surrounded blaCMY-2, which
was found to be highly conserved, was analyzed for three separate plasmid replicons.
MATERIALS AND METHODS
Strains used in the study. The 35 ceftriaxone-resistant isolates used in the
study are listed in Table 1. The isolates were collected from 1998 to 2001 through
either NARMS or the Nebraska Public Health Laboratory. Representative Escherichia coli transformants carrying type A, B, and C plasmids harboring blaCMY-2
were as follows: C6/pNF34 (type A), DH/pNF4656 (type C), and C6/pNF1358
(type B) (11). DH/pIW759 is a type D plasmid isolated from a Salmonella
enterica serotype Heidelberg strain (porcine origin) in Iowa (37, 38).
Plasmid transfer. Plasmids carrying blaCMY-2 were transferred to E. coli
through either transformation, conjugation, or electroporation. Transformation
was performed with E. coli DH5␣ (Invitrogen, Carlsbad, Calif.) according to the
manufacturer’s recommendations, while E. coli DH10B (Invitrogen) was electroporated by using the method described by Sheng et al. (31). Conjugation was
performed by using E. coli C600N (ampicillin susceptible, nalidixic acid resistant)
as previously described (3, 27). Transformants and electroporants were selected
on Luria-Bertani agar (Difco, Detroit, Mich.) containing 50 g of ampicillin
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TABLE 2. Primers used to amplify junction region between each plasmid replicon and the blaCMY-2 region
Primer sequencea

Region

pNF1358 upstream junction (type B)
pNF1358 downstream junction (type B)
pNF4656 upstream junction (type C)
pNF4656 downstream junction (type C)
pIW759 upstream junction (type D)
pIW759 downstream junction (type D)
a

For, GTCATCAGACCTGTGCG
Rev, CGGAAATATCAAACTCGT
For, GTGTATTTCAGGCCAATCGC
Rev, CTGGGTATTCTCTGGTGCA
For, GACACCTTGCCGTTAATC
Rev, CGGAAATATCAAACTCGT
For, GCGAGACGCACTCCAGTC
Rev, CTGTTGCAAATAGTCGGTG
For, CGCTGAACATGAAAGGA
Rev, CGGAAATATCAAACTCGT
For, GCGAGACGCACTCCAGTC
Rev, GCTGTATACGCAGTGCTTT

Amplicon size (bp)

505
659
523
1,378
706
641

Abbreviations: For; forward primer. Rev; reverse primer.

RESULTS
Plasmid typing. In a previously published study, blaCMY-2carrying plasmids isolated from three Salmonella serotypes
were placed into three categories (A, B, and C) based on

RFLP and Southern blot analyses (11). Thirty-five additional
ceftriaxone-resistant isolates were obtained from the NARMS
program (n ⫽ 26) and the Nebraska Public Health Laboratory
(n ⫽ 9) from 1999 to 2001 (Table 1). Twenty-three of these
isolates belonged to serotype Newport, 10 belonged to serotype Typhimurium, and 1 each belonged to serotypes Agona
and Reading. All 35 of the isolates were resistant to cefoxitin
and ampicillin as well as ceftriaxone (Table 1). Thirty-one
(88.5%) of 35 isolates were also resistant to chloramphenicol,
streptomycin, sulfisoxazole, and tetracycline. Three (8.6%) and
six (17.1%) were resistant to kanamycin and trimethoprimsulfamethoxazole, respectively. None of the isolates were resistant to ciprofloxacin, gentamicin, or nalidixic acid. PCR experiments demonstrated that all Salmonella isolates encoded a
blaCMY-2-like ␤-lactamase, as predicted (data not shown) (11,
14).
Plasmid transfer experiments were performed for all 10 serotype Typhimurium isolates, isolate 2042 (serotype Agona),
isolate 2151 (serotype Reading), and 14 serotype Newport
isolates (representing the nine PFGE groups delineated; see
below) by using either conjugation, transformation, or electroporation (Table 1). For all 26 Salmonella isolates, we were able
to transfer plasmid DNA resulting in decreased ceftriaxone
susceptibility to E. coli (either C600N, DH5␣, or DH10B) by
one of the three methods of transfer. PFGE demonstrated that
all E. coli transconjugants, transformants, and electroporants
(referred to collectively as transformants below) were of the
appropriate genomic lineage and were not contaminants (data
not shown). Plasmid DNA was isolated from the E. coli transformants, digested with PstI, electrophoresed by PFGE, and
analyzed by Southern hybridization using blaCMY-2 as a probe.
The resulting RFLP patterns from all transformants were consistent with either a type A, B, or C plasmid as previously
described by Carattoli et al. (11). None of the isolates carried
a type D plasmid. Figure 1 shows a PstI digest and a subsequent Southern blot after hybridization with blaCMY-2 of the
four known plasmid types (A to D). The blaCMY-2 probe hybridizes to an 800-bp fragment in all four plasmid types,
whereas it hybridizes to a band of ⬎12 kb in type A plasmids,
a 2.5-kb band in type B plasmids, a 3.2-kb band in type C
plasmids, and a 9.3-kb band in type D plasmids. Four of the 10
serotype Typhimurium E. coli transformants carried type A
plasmids, 5 carried type B plasmids, and 1 carried a type C
plasmid. Both D10/2151 (serotype Reading) and D10/2042 (se-
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(Sigma, St. Louis, Mo.)/ml. All blaCMY-2 C600N, DH5␣, and DH10B transconjugants, transformants, or electroporants were named either C6, DH, or D10
(standing for C600N, DH5␣, or DH10B, respectively) followed by the appropriate wild-type Salmonella strain designation. Antimicrobial susceptibility testing
of Salmonella and E. coli, as well as E. coli ATCC 25922 (quality control strain),
was performed by using disk diffusion according to NCCLS standards (25). The
following antimicrobial agents were tested: ampicillin, cefoxitin, ciprofloxacin,
tetracycline, chloramphenicol, kanamycin, streptomycin, gentamicin, sulfamethoxazole, trimethoprim-sulfamethoxazole, and nalidixic acid. Susceptibility to
ceftriaxone was determined by using the E-test according to the manufacturer’s
recommendations (AB-Biodisk, Solna, Sweden).
DNA sequencing. The plasmid-harbored blaCMY-2 regions from pNF4656 and
pNF1358 were cloned and sequenced by first preparing plasmid DNA from E.
coli DH/pNF4656 and E. coli C6/pNF1358. DNA was extracted by using a
QIAGEN (Valencia, Calif.) large-construct kit. The DNA was air sheared into
1.0- to 1.5-kb fragments according to the manufacturer’s recommendations (Invitrogen) and cloned into the pCR 4 blunt-TOPO vector (Invitrogen). The
genomic library was transformed into E. coli Top10 cells (Invitrogen), and random clones (approximately 4⫻ coverage) were sequenced on a LiCor (Lincoln,
Nebr.) 4000 sequencer by using IR800-labeled T3 and T7 primers (13, 21).
Contigs were generated by using Vector NTI Contig Express software (Informax,
North Bethesda, Md.).
Molecular methods. All restriction enzymes used in the study were purchased
from Invitrogen. Southern blot hybridizations were performed by standard methods (30) with a blaCMY-2-specific DNA probe labeled with digoxigenin ddUTP
(Roche, Indianapolis, Ind.). The primers used to amplify a blaCMY-specific
probe, or to detect the gene, have been described previously (11). The primers
shown in Table 2 were used to amplify the junction regions between the plasmid
sequence and ISEcp1 upstream of blaCMY-2 and between the plasmid sequence
and sugE (type B) or ecnR (types C and D) downstream of blaCMY-2 in pNF1358
(type B), pNF4656 (type C), and pIW759 (type D).
PFGE. Genomic DNA suitable for pulsed-field gel electrophoresis (PFGE)
was prepared according to standard methods outlined by PulseNet (15, 34).
Salmonella enterica serotype Braenderup H9812 was used as a standard. The
DNA embedded in agarose was digested with XbaI and electrophoresed on a
CHEF DR-III instrument (Bio-Rad, Richmond, Calif.) by using the following
conditions: initial switching time, 2.2 s; final switching time, 63.8 s; total time,
19 h. Salmonella plasmid DNA was digested with PstI and electrophoresed by
using the following conditions: initial switching time, 0.1 s; final switching time,
12 s; total time, 6 h. The RFLP patterns were compared by using Bionumerics
software (Applied Maths, Kortrijk, Belgium) with a 0.75% molecular weight
position tolerance.
Nucleotide sequence accession numbers. The GenBank accession numbers for
ISEcp1 and the C. freundii ampR and ampC region are AY125469 and
AY125469, respectively. The accession numbers for the DNA sequences of the
blaCMY-2 regions from pIW759, pNF1358, and pNF4656 are AY581205,
AY581206, and AY581207, respectively.
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rotype Agona) carried type A plasmids, whereas all serotype
Newport E. coli transformants carried type C plasmids. All E.
coli transformants that carried type A or type C plasmids were
resistant to multiple classes of antibiotics, whereas those that

carried type B plasmids were resistant only to ␤-lactam antibiotics (ceftriaxone, cefoxitin, and ampicillin) (Table 1). In 22
of 26 isolates, the E. coli transformants were resistant to all of
the same antibiotics as wild-type Salmonella.
PFGE. PFGE was performed on all ceftriaxone-resistant
serotype Typhimurium and serotype Newport isolates. All serotype Typhimurium isolates had divergent PFGE patterns, as
previously demonstrated with the 1996-to-1998 ceftriaxoneresistant isolates (data not shown) (14). In contrast, PFGE
patterns were highly related for all serotype Newport isolates,
as has been reported previously (Fig. 2) (6, 17, 29). Among the
23 serotype Newport isolates, nine distinguishable but similar
RFLP patterns were identified (A to I) (Table 1). The most
highly represented PFGE group was group A, which consisted
of 10 isolates; group B consisted of 3 isolates, and groups C, D,
and E consisted of 2 isolates each. The remaining isolates (n ⫽
4) had unique PFGE patterns (F to I). Plasmid typing demonstrated that, regardless of PFGE type, the blaCMY-2-carrying
type C plasmids found in all serotype Newport isolates were
very similar. Figure 3 shows plasmid DNA following digestion
with PstI and a Southern blot using blaCMY-2 as a probe for five
serotype Newport transformants (representing four of nine
PFGE groups). Note that the only detectable difference between these plasmids is a ⬃11- to 12-kb band in C6/5561 (Fig.
3A, lane 5) and a 2.7-kb band in DH/pNF4656 (Fig. 3A, lane
2). For those isolates of serotype Newport for which no attempt was made to isolate a transformant with decreased susceptibility to ceftriaxone, wild-type plasmid DNA was isolated
and digested with PstI. In all cases, Southern blot analysis with

FIG. 2. (A) PFGE RFLP patterns of serotype Newport isolates resistant to expanded-spectrum cephalosporin. The strain number, followed by
the PFGE group designation, is given above each lane. STD, standard. (B) Dendrogram of RFLP patterns shown in panel A following
normalization and analysis with Bionumerics software. Strain numbers, followed by PFGE group designations, are given on the right.
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FIG. 1. (A) PstI digest of the four known blaCMY-2-containing plasmid types. Lanes: 1, 1-kb ladder (Promega, Madison, Wis.); 2, C6/
pNF34 (type A); 3, C6/pNF1358 (type B); 4, DH/pNF4656 (type C); 5,
DH/pIW759 (type D). Sizes of the DNA ladder markers are given on
the left. (B) Subsequent Southern hybridization of the gel in panel A
probed with full-length blaCMY-2. Sizes of bands hybridizing to the
blaCMY-2 DNA probe, as explained in the text, are given on the right.

ANTIMICROB. AGENTS CHEMOTHER.

VOL. 48, 2004

a blaCMY-2 probe demonstrated that each serotype Newport
isolate carried a type C plasmid.
Relatedness of plasmid types A and C. Due to the highly
similar PstI RFLP patterns of the type A and C plasmids, it was
hypothesized that they were related replicons. To address this
question, plasmid DNA was prepared from C6/pNF34 (type A)
and DH/pNF4656 (type C) and digested with HincII. HincIIdigested C6/pNF1358 was used as a negative control. As predicted, the HincII RFLP patterns were similar for type A and
C plasmids, whereas that for type B was divergent (Fig. 4).
Southern blot analysis, using pNF4656 as a probe, demonstrated that pNF4656 hybridized to each distinguishable HincII
band in pNF34. In contrast, pNF4656 hybridized to only three
HincII bands from pNF1358.
DNA sequence of region surrounding blaCMY-2. Plasmid libraries from DH/pNF4656 and C6/pNF1358 were generated
by using the pCR4 blunt-TOPO vector, and ⬃500 clones were
sequenced for both the DH/pNF4656 and C6/pNF1358 libraries (⬃4⫻ coverage). In contrast, the DNA sequence of the
blaCMY-2 region from pIW759 was generated by using primers
within blaCMY-2, and sequencing was carried out from the
native plasmid in both directions. Subsequent DNA sequencing primers were then constructed through the DNA sequence
generated. After the blaCMY-2 gene and the regions surrounding blaCMY-2 were identified, it became apparent that these
regions were highly conserved in all three plasmid types
and had the same general organization as that already described for pTKH11, a plasmid carrying blaCMY-5 isolated
from Klebsiella oxytoca (Fig. 5) (39). Including ISEcp1 (see
below) upstream of blaCMY-2 to the 5⬘ end of the blc gene,
there was 100% sequence identity among all three plasmid
types and 99.3% sequence identity to the same region in
pTKH11.

2849

The sequences of all three plasmids immediately downstream of blaCMY-2 contained open reading frames (ORFs)
that had 96.3 and 96.9% sequence identity, respectively, to blc
and sugE, two genes found just downstream of the C. freundii
chromosomal blaampC gene. In C. freundii, blc encodes an outer
membrane lipoprotein whereas sugE is hypothesized to be a
member of the small multidrug resistance (SMR) family of
multidrug efflux systems (8, 16, 26). Therefore, neither of these
genes is thought to be involved in blaCMY-2 regulation (39).
Upstream and adjacent to sugE in the type C and D plasmids
is partial sequence (364 bp) of an ORF that has 96.7% sequence identity to ecnR (599 bp), a gene which is found just
upstream of sugE in the C. freundii chromosome (7). ecnR
encodes the response regulator for ecnAB, which acts as an
antidote-toxin gene pair involved in programmed cell death.
Adjacent to and downstream of the truncated ecnR, there is a
405-bp region that is shared by type C and D plasmids. No
significant identity to any known bacterial DNA sequence was
found in this region. Adjacent to this common region, an IS26
insertion sequence was found in the type C plasmid but not in
the type D plasmid (23). BLAST searches demonstrated that
DNA sequence generated from pIW759 outside of the
blaCMY-2 region was not found in the DNA sequence from
pNF4656 or pNF1358, suggesting that the type D plasmid is an
independent replicon and was not once part of a composite
plasmid with either a type B or a type C plasmid. Located
just upstream of blaCMY-2 is an ORF with 99.8% sequence
identity with ISEcp1 (20). ISEcp1 is inserted at bp 942 of the
C. freundii ampR-ampC promoter region. The region into
which ISEcp1 inserts is known to be an AmpR binding
region (Fig. 6). The DNA sequence is divergent in all three
plasmid replicons immediately adjacent to the left inverted
repeat of ISEcp1.
blaCMY-2 region junction. By using known sequence upstream and downstream of the blaCMY-2-carrying region (Fig.
5), primers were generated (Table 2) to amplify the junction
regions between the plasmid sequence and ISEcp1 on one end
(left end) and sugE (type B) or ecnR (types C and D) and the
plasmid sequence on the other (right end). Because sequence
downstream of IS26 was not available (sequencing of pNF4656

FIG. 4. (A) HincII digest of plasmid types A, B, and C. Lanes; 1,
1-kb ladder (BRL, Bethesda, Md.); 2, C6/pNF34 (type A); 3, C6/
pNF1358 (type B); 4, DH/pNF4656. (B) Subsequent Southern hybridization of gel in panel A probed with whole pNF4656 DNA.
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FIG. 3. (A) PstI digest of serotype Newport type C plasmids.
Lanes: 1, 1-kb ladder (Promega); 2, DH/pNF4656; 3, D10/4962 (PFGE
group E); 4, DH/5501 (PFGE group A); 5, C6/5561 (PFGE group C);
6, D10/7040 (PFGE group B); 7, D10/7073 (PFGE group A). Arrow A
indicates a ⬃11- to 12-kb band in C6/5561, and arrow B indicates a
2.7-kb band in DH/pNF4656; these bands constitute the only differences in the plasmid RFLP patterns, as discussed in the text. (B) Subsequent Southern hybridization of the gel in panel A probed with
full-length blaCMY-2. Sizes of bands hybridizing to the blaCMY-2 probe,
as explained in the text, are given on the right.
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is not complete), the right-end junction primer for the type C
plasmid was designed from sequence within IS26. Specific leftend primers designed from pNF4656 (type C) generated the
expected products in all 23 type C plasmids and all 6 type A

plasmids (data not shown). In contrast, the right-end primers
designed from pNF4656 did not amplify an appropriate product in any of the 23 type C plasmids or in any of the 6 type A
plasmids. Both right-end and left-end primers designed from

FIG. 6. Comparison of region upstream of blaCMY-2 in pNF4656 and the ampR-ampC promoter region from C. freundii.
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FIG. 5. Map of blaCMY-2 regions from plasmid types B, C, and D in comparison with that from pTKH11. IRL, left inverted repeat; IRR, right
inverted repeat. blc, sugE, and ecnR encode bacterial lipocalin, a small multidrug resistance protein, and the response regulator for the enterocidin
gene, respectively.
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pNF1358 amplified the expected products in all five type B
plasmids. Left-end and right-end primers specific for pIW759
(type D) did not amplify a product in any type A, B, or C
plasmid (data not shown).
DISCUSSION

stream of blaCTX-M-19 in a Klebsiella pneumoniae isolate obtained in Vietnam (28). It was hypothesized, but not experimentally demonstrated, that ISEcp1B was responsible for the
movement of blaCTX-M-19, because a separate inverted repeat
with consistent nucleotide identity to the right inverted repeat
of ISEcp1B was found downstream of blaCTX-M-19. In addition,
primer extension studies demonstrated the presence of a promoter element just upstream of the right inverted repeat that
directed the transcription of blaCTX-M-19. Therefore, ISEcp1B
was hypothesized to be responsible not only for the movement
of blaCTX-M-19 but also for its expression.
The DNA sequence comparison between the ampR-ampC
intergenic promoter region in C. freundii and the region upstream of blaCMY-2 in pNF4656 is shown in Fig. 6. This analysis
demonstrated that ISEcp1 inserted into AmpR binding region
1 in pNF4656. DNA binding studies have demonstrated that
AmpR binds to region 1 but binds to region 2 only in the
presence of region 1 (5, 18). These data strongly suggest that
AmpR would not be able to activate or induce transcription
from blaCMY-2 in pNF4656 if present. The proposed promoter
from C. freundii blaampC is present in pNF4656, but it is not
known what effect ISEcp1 has on its function. The promoter
sequence found within ISEcp1B, which has been shown to
drive the transcription of blaCTX-M-19, is also found in ISEcp1
upstream of blaCMY-2. The effect of this putative promoter
sequence on blaCMY-2 transcription is unknown and warrants
further study. In contrast to what was found for the relationship of ISEcp1B and blaCTX-M-19, no separate inverted repeat
was found downstream of the blaCMY-2 region in any of the
three plasmids sequenced. Multiple experiments attempting to
demonstrate mobility of the blaCMY-2 region from pNF1358 to
other plasmids were not successful (data not shown).
In conclusion, this work demonstrates that blaCMY-2 is
spread primarily through plasmid transfer and not through the
mobilization of a transposon or integron to multiple plasmid
replicons and chromosomes. These findings were unexpected,
because Morosini and colleagues have demonstrated that salmonellae carrying a plasmid-encoded, Enterobacter cloacaederived AmpC ␤-lactamase had a reduction in growth rate and
were less invasive by an in vitro cell invasion assay (24). The
pathogenesis of Salmonella spp. is dependent on the organism’s ability to adhere to and invade intestinal epithelial cells.
Therefore, one would predict that the prevalence of AmpCproducing salmonellae would be very low, because these
strains would be less physiologically fit. Alternatively, the predicted decreased fitness may be counterbalanced by the selective pressure of antimicrobial usage, compensatory mutations
within certain genomic backgrounds of Salmonella, varying
effects on invasiveness and/or fitness associated with different
species-derived AmpC ␤-lactamases, and/or regulation of the
blaampC gene itself (i.e., promoter strength).
ACKNOWLEDGMENT
W.P.G. is supported through a USDA National Needs Fellowship.

ADDENDUM IN PROOF
Hossain et al. have recently described an S. enterica serotype
Typhimurium strain that carried a blaCMY-7 gene (A. Hossain,
M. D. Reisbig, and N. D. Hanson, J. Antimicrob. Chemother.
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The purpose of this study was to determine the extent to
which the four characterized plasmid replicons that carry
blaCMY-2 were found within 35 expanded-spectrum cephalosporin-resistant salmonellae collected from 1999 to 2001. These
four plasmid types (types A to D) have been characterized previously in two separate studies (11, 38). In the present study,
transfer of blaCMY-2 through conjugation to E. coli C600N was
predictably successful only when a type B plasmid was being
transferred. Conjugal transfer of type A and C plasmids was
less successful, and transfer frequencies were extremely low
(10⫺8). It is not known whether the majority of type A and C
plasmids were defective in conjugal transfer or whether these
observations are an experimental artifact. It was determined,
however, that electroporation using the method of Sheng
et al. (31) was an extremely reliable method of transferring
blaCMY-2-containing plasmids from salmonellae to E. coli
DH10B.
The observation that similar blaCMY-2-carrying plasmids
were observed in two temporally distinct strain sets (the 1996to-1998 set and the present strain set of 1999 to 2001) suggests
that blaCMY-2 has moved to separate genomic backgrounds
through plasmid transfer, as opposed to transfer of the element
itself to separate plasmids or the chromosome (11). Within
serotype Typhimurium, the most prevalent serotype isolated
from humans, three plasmid types (types A, B, and C) were
found in multiple genomic backgrounds. In contrast, only one
blaCMY-2-containing plasmid type, type C, was found within the
population of highly related ceftriaxone-resistant serotype
Newport isolates. No isolates were found to contain a type D
plasmid. Preliminary data suggest that the smaller pIW759-like
plasmids are more common within E. coli populations than
within salmonellae (P.L. Winokur, unpublished data). Since
our Southern hybridization data suggest that plasmid types A
and C are highly related, it appears that two variants of the
same plasmid are mostly responsible for the dissemination of
blaCMY-2 within ceftriaxone-resistant salmonellae in the
United States (30 of 35 isolates belong to either type A or type
C). Primers designed to identify the junction regions between
the blaCMY-2 region and plasmid sequence demonstrate that
the junction near ISEcp1 is conserved in type A and C plasmids. However, downstream, near ecnR, all 30 type A or C
plasmids diverge from the representative type C plasmid,
pNF4656. This result is not unexpected, since one of the primers used to amplify the right-end junction from pNF4656 was
designed within a mobile element, IS26. Further DNA sequencing is needed to determine whether the right-end junction sequence within type A and C plasmids is conserved. One
potential reason for the RFLP differences seen between type A
and C plasmids is the fact that type A plasmids contain at least
twice as many IS26 elements as type C plasmids (data not
shown).
Recently, Poirel et al. reported that ISEcp1B, an insertion
sequence element highly related to ISEcp1, was found up-

2851

2852

GILES ET AL.

ANTIMICROB. AGENTS CHEMOTHER.

53: 964–970, 2004). A promoter within an ISEcp1-like element,
which was located just upstream of blaCMY-7 at the identical
nucleotide position as described in the present study, was
shown to drive transcription of blaCMY-7.
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